Serum albumin has been widely used as a valuable marker and therapeutic agent in critically ill patients, including those with shock, hypovolemia, cancer, acute respiratory distress syndrome, liver disease, resuscitation, and PCAS [12,28,29,30]. This evidence concerns the gene ALB and acute respiratory distress syndrome.